HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ping Sun Selected Research

human AOC3 protein

3/2021SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease.
2/2018Simvastatin blocks soluble SSAO/VAP-1 release in experimental models of cerebral ischemia: Possible benefits for stroke-induced inflammation control.
1/2014Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemia.
6/2013A therapeutic approach to cerebrovascular diseases based on indole substituted hydrazides and hydrazines able to interact with human vascular adhesion protein-1, monoamine oxidases (A and B), AChE and BuChE.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ping Sun Research Topics

Disease

94Neoplasms (Cancer)
09/2022 - 11/2003
88Breast Neoplasms (Breast Cancer)
07/2022 - 12/2002
25Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 01/2005
19Hepatocellular Carcinoma (Hepatoma)
10/2021 - 08/2009
14Inflammation (Inflammations)
12/2022 - 01/2018
13Neoplasm Metastasis (Metastasis)
09/2022 - 01/2012
12Stroke (Strokes)
12/2021 - 06/2012
11Alzheimer Disease (Alzheimer's Disease)
03/2022 - 06/2013
9Carcinoma (Carcinomatosis)
08/2021 - 01/2006
9Hypertension (High Blood Pressure)
04/2021 - 07/2005
9Carcinogenesis
02/2021 - 11/2005
7Cognitive Dysfunction
03/2022 - 07/2013
6Triple Negative Breast Neoplasms
05/2022 - 08/2007
6Spinal Cord Injuries (Spinal Cord Injury)
03/2022 - 01/2015
6Fallopian Tube Neoplasms
01/2022 - 07/2006
6Brain Injuries (Brain Injury)
12/2021 - 01/2017
5Osteoporosis
12/2022 - 04/2010
5Ischemic Stroke
03/2022 - 01/2014
5Lymphatic Metastasis
03/2021 - 01/2008
5Melanoma (Melanoma, Malignant)
06/2013 - 12/2006
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2022 - 04/2016
4Dementia (Dementias)
03/2022 - 07/2013
4Sepsis (Septicemia)
01/2022 - 07/2014
4Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020 - 03/2016
4Ischemia
01/2020 - 06/2010
4Laryngeal Neoplasms (Laryngeal Cancer)
07/2018 - 01/2013
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2015 - 12/2003
4Marijuana Use
01/2015 - 07/2007
3Bone Resorption
12/2022 - 01/2020
3Colorectal Neoplasms (Colorectal Cancer)
09/2022 - 09/2012
3Infections
03/2022 - 06/2009
3Wounds and Injuries (Trauma)
03/2022 - 01/2018
3Reperfusion Injury
01/2022 - 10/2020
3Glioma (Gliomas)
01/2022 - 01/2020
3Myocardial Infarction
01/2022 - 01/2017
3Atherosclerosis
01/2021 - 01/2012
3Adenocarcinoma of Lung
01/2021 - 11/2012
3Cerebral Infarction
04/2020 - 02/2010
3Fibrosis (Cirrhosis)
01/2020 - 01/2016

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
09/2022 - 11/2005
19MicroRNAs (MicroRNA)IBA
03/2022 - 01/2015
17Pharmaceutical PreparationsIBA
03/2022 - 07/2007
17Estrogen ReceptorsIBA
09/2017 - 03/2004
15TamoxifenFDA LinkGeneric
07/2017 - 06/2004
14Biomarkers (Surrogate Marker)IBA
09/2022 - 06/2013
11Small Interfering RNA (siRNA)IBA
01/2022 - 11/2005
10Messenger RNA (mRNA)IBA
12/2022 - 01/2006
10Oral ContraceptivesIBA
01/2022 - 12/2002
9Biological ProductsIBA
09/2022 - 04/2005
9EnzymesIBA
10/2020 - 02/2008
8Glucose (Dextrose)FDA LinkGeneric
03/2022 - 07/2005
7DNA (Deoxyribonucleic Acid)IBA
06/2022 - 04/2002
7Progesterone Receptors (Progesterone Receptor)IBA
03/2019 - 08/2007
6ErbB Receptors (EGF Receptor)IBA
09/2022 - 04/2005
6Long Noncoding RNAIBA
03/2022 - 10/2015
6Therapeutic UsesIBA
02/2022 - 02/2010
6Insulin (Novolin)FDA Link
01/2022 - 03/2010
6LigandsIBA
01/2020 - 12/2003
6Cisplatin (Platino)FDA LinkGeneric
03/2016 - 01/2006
5CytokinesIBA
06/2022 - 11/2003
5Hormones (Hormone)IBA
05/2022 - 06/2005
5Peptides (Polypeptides)IBA
01/2022 - 05/2012
5InflammasomesIBA
08/2021 - 01/2020
5Estrogens (Estrogen)FDA Link
01/2021 - 10/2008
5Dihydrotachysterol (AT 10)IBA
10/2015 - 10/2003
4RNA (Ribonucleic Acid)IBA
06/2022 - 01/2020
4human AOC3 proteinIBA
03/2021 - 06/2013
4Indicators and Reagents (Reagents)IBA
01/2021 - 12/2008
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2020 - 09/2012
4Streptozocin (Streptozotocin)FDA Link
08/2020 - 01/2015
4Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 03/2013
4SeleniumIBA
01/2019 - 01/2013
4Phosphotransferases (Kinase)IBA
08/2015 - 06/2006
3Tyrosine Kinase InhibitorsIBA
09/2022 - 01/2019
3Antiviral Agents (Antivirals)IBA
06/2022 - 03/2014
3human ERBB2 proteinIBA
05/2022 - 11/2009
3Oxygen (Dioxygen)IBA
03/2022 - 06/2012
3Transcription Factors (Transcription Factor)IBA
03/2022 - 06/2018
3MicellesIBA
01/2022 - 01/2020
3C-Reactive ProteinIBA
01/2022 - 07/2014
31-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2021 - 09/2013
3Triglycerides (Triacylglycerol)IBA
05/2021 - 04/2006
3ceramide glucosyltransferaseIBA
03/2021 - 01/2014
3Carrier Proteins (Binding Protein)IBA
01/2021 - 12/2008
3CarcinogensIBA
01/2020 - 03/2009
3ChitosanIBA
01/2020 - 01/2016

Therapy/Procedure

45Therapeutics
06/2022 - 11/2003
33Ovariectomy (Oophorectomy)
01/2022 - 06/2004
23Drug Therapy (Chemotherapy)
07/2022 - 01/2005
17Mastectomy (Mammectomy)
06/2021 - 06/2004
9Radiotherapy
01/2019 - 01/2005
8Salpingo-oophorectomy
12/2020 - 07/2006
6Prophylactic Mastectomy
09/2021 - 08/2007
6Neoadjuvant Therapy
06/2021 - 09/2014
5Hormone Replacement Therapy (Therapy, Hormone Replacement)
06/2021 - 01/2006
5Segmental Mastectomy (Lumpectomy)
01/2016 - 07/2006
4Photochemotherapy (Photodynamic Therapy)
10/2021 - 09/2013
3Immunotherapy
01/2022 - 01/2021
3Intravenous Administration
12/2021 - 08/2016
3Ligation
01/2020 - 01/2016